Bormioli Pharma issues a binding offer to acquire GCL Pharma

Bormioli Pharma announces today the issuing of a Binding Offer for the acquisition of 100% of GCL Pharma, an Italian subsidiary of the Guala Closures Group, specialized in the production of plastic, rubber and aluminum closures for pharmaceutical applications. Bormioli Pharma, a company leader in the production of pharmaceutical glass and plastic primary packaging, continues investing to become a stronger player in the sector. This further acquisition that follows the one of Remy and Geiser completed last Autumn would allow the company to enlarge its product range, consolidating its ability to support the most demanding Pharma players. In 2019 GCL Pharma recorded a turnover of approximately Euro 8 million (approximately Rs 65 crore). Over the years, the company has demonstrated strong innovation capabilities by continuously improving its product range to meet the most stringent pharma standards. The company’s main premises and production plant are located in Vasto (Chieti). The aggregate purchase price offered for the acquisition is Euro 8.9 million (approximately Rs 65 crore). Andrea Lodetti, chief executive officer of Bormioli Pharma, said, “With the…

Choose your subscription to read more